SCHEMBL4841137

SCHEMBL4841137

COC(=O)CCCCCNC(=O)[C@@H]1Cc2ccccc2N1S(=O)(=O)c1ccc(-c2ccccc2C(F)(F)F)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.39
PTGER3 P43115 1/20 0.38
MMP1 P03956 1/20 0.36
MMP2 P08253 1/20 0.36
MMP9 P14780 1/20 0.36
MMP14 P50281 1/20 0.36
ADAM17 P78536 1/20 0.36
KDM2B Q8NHM5 1/20 0.36
ALDH1A1 P00352 2/20 0.36
KDM4E B2RXH2 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
SCN9A Q15858 1/20 0.36
RORC P51449 1/20 0.36
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
KDM1A O60341 1/20 0.35
MAOA P21397 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4842444 0.97 MAPK1 (0.40) MAPK1PTGER3MMP1MMP2MMP9
SCHEMBL4840706 0.91 FFAR4 (0.42) MAPK1PTGER3MMP1MMP2MMP9
SCHEMBL4841693 0.90 FFAR4 (0.43) MAPK1PTGER3MMP1MMP2MMP9
SCHEMBL4203772 0.90 MAPK1 (0.42) MAPK1PTGER3MMP1MMP2MMP9
SCHEMBL4842900 0.88 FFAR4 (0.43) MAPK1PTGER3MMP1MMP2MMP9
SCHEMBL4039819 0.87 MAPK1 (0.40) MAPK1PTGER3MMP1MMP2MMP9
SCHEMBL4032860 0.87 MAPK1 (0.40) MAPK1PTGER3MMP1MMP2MMP9
SCHEMBL4030753 0.87 HTR7 (0.46) MAPK1MMP1MMP2MMP9MMP14
SCHEMBL4843354 0.86 RORC (0.40) MAPK1PTGER3RORCMMP8MMP3
SCHEMBL4034006 0.85 MMP1 (0.40) MAPK1PTGER3MMP1MMP2MMP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7465811-B2 Indoline compounds LABORATOIRES FOURNIER S.A. (FR) 2008-12-16 US disclosed
US-20080119465-A1 Novel Indoline Compounds LABORATORIES FOURNIER S.A. (FR) 2008-05-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080119465-A1 Novel Indoline Compounds GPR119, INSR, IRS1 MAPK1 870/4885PTGER3 3044/4885MMP1 3209/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.